Levorphanol structure

Main Outcome Measures: Pathologic response of treated sites was assessed at 6 months. Clinical and cosmetic responses were assessed and graded at 6 weeks, 3 months, and 6 months after verteporfin PDT, with optional follow-up visits at 12, 18, and 24 months. Results: The histopathologic response, defined as ab Verdicts ever upheld on appeal. State Farm's petition for discretionary review by the Illinois Supreme Court was recently granted, and briefing is underway. 2. Providian Credit Card Cases, No. JCCP 4085 San Francisco Superior Ct. ; . Lieff Cabraser served as Co-Lead Counsel for a certified national Settlement Class of Providian credit cardholders who alleged that Providian had engaged in widespread misconduct by charging cardholders unlawful, excessive interest and late charges, and by promoting and selling to cardholders "add-on products" promising illusory benefits and services. In November 2001, the Hon. Stuart R. Pollak granted final approval to a 5 million settlement of the case, which also required Providian to implement substantial changes in its business practices. The 5 million settlement, combined with an earlier settlement by Providian with Federal and state agencies, represents the largest settlement ever by a U.S. credit card company in a consumer protection case. In re Synthroid Marketing Litigation, MDL No. 1182 N.D. Ill. ; . Lieff Cabraser serves as Co-Lead Counsel for the purchasers of the thyroid medication Synthroid in litigation against Knoll Pharmaceutical, the manufacturer of Synthroid. The lawsuits charge that Knoll misled physicians and patients into keeping patients on Synthroid despite knowing that less costly, but equally effective drugs, were available. Specifically, Knoll's predecessor, Boots Laboratories, sponsored a university study to determine whether Synthroid and a number of less expensive thyroid hormone products were "bioequivalent." The authors of the study concluded in 1990 that Levoxyl and two generic thyroid hormone products were bioequivalent to Synthroid, and could therefore be substituted for Synthroid at substantial cost savings. Knoll denied the authors permission to publish the study, and its contents were not revealed until 1997. In August 2000, U.S. District Court Judge Elaine E. Bucklo gave final approval to a .4 million settlement with Knoll and its parent company, BASF Corporation, on behalf of a class of all consumers who purchased Synthroid at any time from January 1, 1990 until October 21, 1999. After a series of appeals, the settlement proceeds were distributed to the fall of 2003. Citigroup Loan Cases, JCCP No. 4197 San Francisco Superior Ct. ; . Prior to its acquisition in November 2000, Associates First Financial, referred to as The Associates, was one of the nation's largest "subprime" lenders. Lieff Cabraser represents former customers of The Associates and related companies in a class action suit alleging that The Associates packed mortgage loans with unwanted and unnecessary insurance products and engaged in improper loan refinancing practices. In April 2003, the Court granted final approval to a settlement of the action that will provide up to 0 million in relief to former Associates' customers nation-wide.